Glenmark Pharmaceuticals Ltd. (GLENMARK) - Financials, balance sheet (quarterly)

2,225 INR

0.86%

Last update Jul 17, 3:29 PM IST

Market closed

Day range

2,225

2,179.69995

2,265.30005

Previous close

2,206

Open

2,220.30005

Access this stock data via API

Glenmark Pharmaceuticals Ltd.

2,225.00

0.86%

Financials

Balance sheet

Fiscal date	Mar 2025	Sep 2024	Mar 2024	Sep 2023
Total assets	160.5B	152.4B	143.6B	200.1B
Current assets	93.0B	90.3B	74.3B	112.7B
Cash	—	—	16.6B	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	16.8B	18.2B	16.6B	11.2B
Other short term investments	919.7M	2.2B	121.3M	2.3B
Accounts receivable	33.4B	28.6B	18.6B	32.0B
Other receivables	—	—	1.5B	—
Inventory	30.3B	28.4B	25.1B	26.5B
Prepaid assets	—	—	5.7B	—
Restricted cash	—	—	11.9M	—
Assets held for sale	—	—	0	26.2B
Hedging assets	—	—	—	—
Other current assets	11.6B	12.9B	12.2B	14.4B
Non current assets	67.5B	62.0B	69.3B	87.4B
Properties	33.2B	31.6B	31.2B	31.0B
Land and improvements	—	—	461.3M	—
Machinery furniture equipment	—	—	32.8B	—
Construction in progress	5.4B	4.0B	4.5B	12.2B
Leases	—	—	—	—
Accumulated depreciation	—	—	-24.9B	—
Goodwill	15.3B	14.2B	14.0B	25.0B
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	13.9B	12.8B	12.7B	23.6B
Investments and advances	—	—	—	—
Other non current assets	1.8B	1.1B	1.5B	2.0B
Total liabilities	72.0B	67.9B	65.1B	102.7B
Current liabilities	59.7B	61.8B	58.2B	58.4B
Accounts payable	25.8B	23.6B	25.4B	19.2B
Accrued expenses	—	—	—	—
Short term debt	17.7B	16.4B	10.8B	11.4B
Deferred revenue	—	—	—	—
Tax payable	283.7M	1.7B	2.9B	1.2B
Pensions	—	—	—	—
Other current liabilities	2.0B	2.6B	877.2M	3.2B
Non current liabilities	12.3B	6.1B	6.9B	44.3B
Long term provisions	—	—	—	—
Long term debt	7.0B	1.4B	1.5B	40.4B
Provision for risks and charges	—	—	—	—
Deferred liabilities	585.9M	7.9M	2.8M	4.5M
Derivative product liabilities	—	—	—	—
Other non current liabilities	—	—	16.9M	13.6M
Shareholders equity
Common stock	282.2M	282.2M	282.2M	282.2M
Retained earnings	—	—	78.7B	—
Other shareholders equity	—	—	—	—
Total shareholders equity	88.5B	84.5B	78.5B	97.4B
Additional paid in capital	—	—	17.1B	—
Treasury stock	—	—	—	—
Minority interest	-3.7M	-1.6M	-3.8M	4.1B